Suppr超能文献

单剂量全身性对乙酰氨基酚预防术后疼痛:一项随机对照试验的荟萃分析

Single-dose systemic acetaminophen to prevent postoperative pain: a meta-analysis of randomized controlled trials.

作者信息

De Oliveira Gildasio S, Castro-Alves Lucas J, McCarthy Robert J

机构信息

Department of Anesthesiology, Northwestern University, Chicago, IL.

出版信息

Clin J Pain. 2015 Jan;31(1):86-93. doi: 10.1097/AJP.0000000000000081.

Abstract

OBJECTIVES

The effect of a single-dose systemic acetaminophen to treat postoperative pain has been previously quantified, but the effect of systemic acetaminophen to prevent postoperative pain is currently not well defined. The preventive analgesic effect of acetaminophen has yet to be quantified in a meta-analysis. The objective of the current investigation was to evaluate the effect of a single preventive dose of systemic acetaminophen on postoperative pain outcomes.

MATERIALS AND METHODS

A wide search was performed to identify randomized controlled trials that evaluated the effects of a single dose of systemic acetaminophen on pain outcomes in a large variety of surgical procedures. Meta-analysis was performed using a random-effect model.

RESULTS

Eleven randomized clinical trials evaluating 740 patients were included in the analysis. The weighted mean difference (95% confidence interval [CI]) of the combined effects favored acetaminophen over control for early pain at rest (≤4 h, -1.1 (-2.0 to -0.2)) and early pain at movement (24 h, -1.9 (-2.8 to -1.0)) Postoperative opioid consumption was decreased in the systemic acetaminophen group compared with control. Weighted mean difference (95% CI) of -9.7 (-13.0 to -6.4) mg morphine intravenous equivalents systemic acetaminophen also reduced postoperative nausea and vomiting compared with control, odds ratio (95% CI) of 0.25 (0.13 to 0.47), numbers needed to treat (95% CI)=3.3 (2.3 to 5.9).

DISCUSSION

Systemic acetaminophen, when used as a single-dose preventive regimen, is an effective intervention to reduce postoperative pain. It also reduces postoperative nausea and/or vomiting. Doses >1 g were not associated with greater reduction in pain outcomes.

摘要

目的

以往已对单剂量全身性对乙酰氨基酚治疗术后疼痛的效果进行了量化,但全身性对乙酰氨基酚预防术后疼痛的效果目前尚不明确。对乙酰氨基酚的预防性镇痛作用尚未在一项荟萃分析中进行量化。本研究的目的是评估单剂量预防性全身性对乙酰氨基酚对术后疼痛结局的影响。

材料与方法

进行了广泛的检索,以确定评估单剂量全身性对乙酰氨基酚对各种外科手术疼痛结局影响的随机对照试验。采用随机效应模型进行荟萃分析。

结果

纳入分析的有11项评估740例患者的随机临床试验。联合效应的加权平均差(95%置信区间[CI])显示,在静息时早期疼痛(≤4小时,-1.1(-2.0至-0.2))和活动时早期疼痛(24小时,-1.9(-2.8至-1.0))方面,对乙酰氨基酚组优于对照组。与对照组相比,全身性对乙酰氨基酚组术后阿片类药物消耗量减少。全身性对乙酰氨基酚组与对照组相比,吗啡静脉等效剂量的加权平均差(95%CI)为-9.7(-13.0至-6.4)mg,全身性对乙酰氨基酚还降低了术后恶心和呕吐,比值比(95%CI)为0.25(0.13至0.47),需治疗人数(95%CI)=3.3(2.3至5.9)。

讨论

全身性对乙酰氨基酚作为单剂量预防方案使用时,是一种减轻术后疼痛的有效干预措施。它还可减少术后恶心和/或呕吐。剂量>1g与疼痛结局的更大改善无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验